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Macrophage- and RIP3-dependent inflammasome
activation exacerbates retinal detachment-induced
photoreceptor cell death
K Kataoka1,2, H Matsumoto1, H Kaneko2, S Notomi1, K Takeuchi1, JH Sweigard1, A Atik1, Y Murakami1, KM Connor1, H Terasaki2,
JW Miller1 and DG Vavvas*,1
Detachment of photoreceptors from the retinal pigment epithelium is seen in various retinal disorders, resulting in photoreceptor
death and subsequent vision loss. Cell death results in the release of endogenous molecules that activate molecular platforms
containing caspase-1, termed inflammasomes. Inflammasome activation in retinal diseases has been reported in some cases to be
protective and in others to be detrimental, causing neuronal cell death. Moreover, the cellular source of inflammasomes in retinal
disorders is not clear. Here, we demonstrate that patients with photoreceptor injury by retinal detachment (RD) have increased
levels of cleaved IL-1β, an end product of inflammasome activation. In an animal model of RD, photoreceptor cell death led to
activation of endogenous inflammasomes, and this activation was diminished by Rip3 deletion. The major source of Il1b
expression was found to be infiltrating macrophages in the subretinal space, rather than dying photoreceptors. Inflammasome
inhibition attenuated photoreceptor death after RD. Our data implicate the infiltrating macrophages as a source of damaging
inflammasomes after photoreceptor detachment in a RIP3-dependent manner and suggest a novel therapeutic target for treatment
of retinal diseases.
Cell Death and Disease (2015) 6, e1731; doi:10.1038/cddis.2015.73; published online 23 April 2015
Retinal detachment (RD) is characterized as the separation of
neurosensory retina from retinal pigment epithelium (RPE),
and subsequent photoreceptor cell death is themajor cause of
blindness in age-related macular degeneration,1 diabetic
retinopathy,2 and rhegmatogenous RD (RRD).3 The outer
layers of the retina, including photoreceptors, depend on the
choroidal vasculature and choriocapillaris to regulate their
overall metabolic homeostasis. Once RD occurs, photorecep-
tor cells cannot receive sufficient metabolic supply for survival
and begin to undergo apoptosis and necrosis.3–7 Receptor-
interacting protein 3 (RIP3) has been identified as a key
regulator of programmed necrosis.8,9 Recently, we showed
that RD induces RIP3-dependent programmed necrosis.5 The
RIP3-dependent necrotic pathway is not only critical for the
development of various retinal diseases,5,10,11 but also for
several systemic diseases such as acute pancreatitis and
antiviral immunity.8,9,12 Under the specific conditions where
caspase-8 is inactivated, necrotic stimuli such as tumor
necrosis factor α (TNFα), Fas ligand, and Toll-like receptor
(TLR) trigger the formation of a complex called the necrosome,
containing receptor-interacting protein 1 (RIP1), RIP3, and
mixed lineage kinase domain-like protein (MLKL).8,9,13–15
Ultimately, upon phosphorylation of MLKL by RIP3,
oligomerized MLKL is inserted into plasma membranes,
resulting in membrane rupture and necrotic cell death.16–18
Additionally, it is known that dead cells release endogenous
molecules, such as high mobility group box 1 (HMGB1),
ATP, and uric acid.19–22 These molecules, termed damage-
associated molecular patterns (DAMPs), can alert the innate
immune response through pattern-recognition receptors.
It should be noted that some DAMPs such as HMGB1
are released only from necrotic cells and not from apoptotic
cells.19
The inflammasome is a molecular platform that regulates
the activation of caspase-1, which leads to the cleavage of
interleukin-1β (IL-1β).23–25 Recent studies have revealed that
inflammasomes are stimulated by DAMPs (such as ATP and
uric acid crystals) through the NOD-like receptor family, pyrin
domain containing-3 (NLRP3) protein.26,27 Once NLRP3 is
activated, it oligomerizeswith apoptosis-associated speck-like
protein containing a caspase recruitment domain (ASC) and
pro-caspase-1, followed by the autocleavage of caspase-1.
It is reported that necrotic cells, not apoptotic cells, trigger
the NLRP3 inflammasome.28 Other recent reports show
evidence that DAMPs such as HMGB1 and histones are
increased in the vitreous of RD patients.29,30 Recently,
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endogenous inflammasome activation in retinal disorders has
been implicated as either protective or detrimental to neuronal
cell death.31–34 In this study, we investigated whether
inflammasomes are induced in mouse and human eyes with
photoreceptor detachment, and whether loss of RIP3 affects
inflammasome activation in a mouse model of RD. We also
characterized the cellular origin of IL-1β production during RD.
IL-1β is known as a central mediator of the immune response
against acute and chronic diseases, but there is still debate on
whether it is a neurotoxic or neuroprotective agent in vivo.32,34
Here, we revealed that inhibition of IL-1β by caspase-1
inhibitor, neutralization of IL-1β, and NLRP3 depletion can
protect against photoreceptor cell death after RD.
Results
RD triggers the activation of inflammasomes, which is
diminished by Rip3 deletion. We previously demonstrated
that RD leads to both caspase-dependent apoptosis and
RIP3-dependent necrosis of photoreceptor cells, and that
Rip3 deletion diminishes photoreceptor cell death during
RD.5 Furthermore, necrotic cells (rather than apoptotic cells)
have been reported to be the major triggers of the NLRP3
inflammasome.35 Therefore, we investigated whether photo-
receptor cell death during RD is associated with activation of
inflammasomes in humans and in a mouse model of RD.
In human eyes with RD, various cytokines have been
reported to be increased in the subretinal or vitreous fluid.36–38
However, alterations of the inflammasome cytokine IL-1β have
not been previously investigated. We assessed the subretinal
fluid and the vitreous of patients in the early phase of RRD and
the vitreous of control patients (macular hole and vitreoma-
cular traction syndrome) (Table 1). The High Sensitivity ELISA
kit (eBioscience) enabled us to detect extremely low
concentrations of IL-1β (such as 0.05 pg/ml) in samples
compared with the general ELISA kit (Supplementary Figure
S1). Themedian of IL-1β concentration in the subretinal fluid of
RRD patients (0.25 pg/ml, range: 0.10–1.97 pg/ml) was
significantly higher than the vitreous fluid of control patients
(0.02 pg/ml, range: 0.01–0.03 pg/ml) (Figure 1). IL-1β in the
vitreous fluid of RRD patients (0.06 pg/ml, range: 0.001–
0.21 pg/ml) was also elevated, but not to the levels of the
subretinal fluid of RRD patients, probably due to dilution.
These data suggest that RD triggers upregulation of IL-1β in
human eyes, and that IL-1β is concentrated in the subretinal
space. This elevation was somewhat specific, since TNFα
showed no difference among the three groups in accordance
with a previous report in human eyes (Supplementary Figure
S2a).39 In contrast, IL-6 was elevated both in the subretinal
fluid and in the vitreous of RRD patients (Supplementary
Figure S2b) in accordance with a previous report.36
To further characterize the activation of inflammasomes in
photoreceptor injury, we examined the time course of IL-1β
levels in tissues containing subretinal fluid, retina, RPE, and
choroid in a mouse model of RD (Figure 2a). IL-1β was
increased 4.6-fold as early as 6 h after RD, compared with
control eyes, and peaked at 12 h. After 24 h, the level of IL-1β
declined to some extent, although it remained significantly
higher (3.4 times) than control eyes. In the same samples, IL-6
was significantly upregulated, whereas vascular endothelial
growth factor (VEGF) was modestly elevated (Supplementary
Figures S3a and b). TNF was below the detection limit.
Since ELISA cannot reliably distinguish cleaved IL-1β from
pro IL-1β, we used western blotting to better assess levels of
cleaved IL-1β. As seen in Figures 2b and c, RD induced the
production of cleaved IL-1β with a peak at 24 h in both wild-
type (WT) and Rip3− /− mice, although Rip3− /− mice had
significantly lower cleaved IL-1β comparedwithWTmice (69.4
and 64.8% less at 12 and 24 h, respectively) (Figures 2b and c).
In contrast to the significant changes in the mature form of IL-1β,Table 1 Baseline demographics and characteristics of patients in control and
RD group
Characteristics Control
Vit.
SRF of
RD
Vit. of
RD
P-value
Number 7 8 8
Age, years 70.0
(55–76)
37.5
(32–52)
59.0
(45–82)
0.0005a
Sex
Female 3 (42.9) 4 (50) 1 (12.5) NSb
Past history
Hyperlipidemia 1 (14.3) 1 (12.5) 0 (0) NSb
Diabetic mellitus 0 (0) 0 (0) 1 (12.5) NSb
Hypertension 0 (0) 0 (0) 0 (0) NSb
Surgical indication
RRD — 8 (100) 8 (100)
MH 5 (71.4) —
VMTS 2 (28.6) —
Detachment duration, days — 3 (1–4) 8 (0–19) NSc
Abbreviations: MH, macular hole; RD, retinal detachment; RRD, rhegmatogen-
ous RD; SRF, subretinal fluid; Vit., vitreous; VMTS, vitreomacular traction
syndrome
Data are expressed as median (range) or number (%)
aKruskal–Wallis test
bFisher’s exact test
cMann–Whitney U test
Figure 1 Concentration of IL-1β in human eyes with rhegmatogenous retinal
detachment (RRD). IL-1β levels in vitreous fluid of control eyes (n= 7) versus
subretinal fluid (SRF) of eyes with RRD (n= 8) and vitreous fluid of eyes with RRD
(n= 8). Horizontal line indicates median in each group. ***Po0.001
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we did not detect significant differences in the protein levels of
pro IL-1β or NLRP3 between WT and Rip3− /− mice at each
time point (Figures 2b and c) despite modest changes in
mRNA level at 12 h after RD (Supplementary Figures S4a and b),
suggesting that RIP3 has a limited role in priming pro IL-1β
after RD.
Similar to Il1b, RD also led to upregulation of Tnfa and Il6
mRNA (Supplementary Figures S4c and d). Rip3 deficiency
did not affect caspase-3 activation, as cleaved caspase-3
tended to increase in both WTand Rip3− /− mice at 24 h after
RD to a similar extent (Supplementary Figures S5a and b).
Taken together, these results demonstrate that inflamma-
somes are activated after photoreceptor separation from the
RPE in both human and mouse eyes, and that Rip3 deficiency
inhibits inflammasome activation directly or indirectly.
Infiltrating subretinal cells produce IL-1β. In many retinal
degenerative diseases, including RD, macrophages infiltrate
the diseased tissue in response to chemokines such as
monocyte chemoattractant protein 1 (MCP-1).40,41 It is
generally thought that IL-1β is produced and secreted by
monocytes/macrophages, and recent studies have revealed
that other non-immune cells may contain NLRP3 and activate
NLRP3 inflammasomes.31,42 Thus, we assessed the expres-
sion of Il1b mRNA via laser capture microdissection (LCM) in
the outer nuclear layer (ONL), which contains the photo-
receptor cell bodies; the subretinal space, where macro-
phages are mostly seen during RD; and the RPE/choroid
complex. Each part of the eye was microdissected as
indicated in Figure 3a. In non-RD eyes, there was no Il1b
mRNA expression detected in either the ONL or the RPE/
choroid complex (Figure 3b). RD led to a significant increase
of Il1b mRNA expression in the subretinal space compared
with the ONL. Although the sample from the RPE/choroid
complex in RD eyes also showed an increase in Il1bmRNA, it
was not statistically significant. These data suggest that IL-1β
largely originates from cells migrating into the subretinal
space during RD.
Macrophage recruitment in the detached retina is not
altered in Rip3− /− mice. To assess whether inhibition of
cleaved IL-1β in Rip3− /− mice during RD is due to decreased
macrophage recruitment to the site of detachment, we
analyzed the numbers of infiltrating macrophages labeled
with an anti-CD11b antibody in the detached retina, including
the ONL and the subretinal space (Figures 4a and b).
Macrophage infiltration through the entire subretinal space
was noted as early as 12 h after RD, and peaked at 24 h.
Interestingly, the number of macrophages in Rip3− /− mice
was not significantly lower than WT mice, suggesting that the
decrease in inflammasomes and cleaved IL-1β is not due to
impaired macrophage recruitment in Rip3− /− mice after RD.
Inhibition of IL-1β diminishes photoreceptor cell death
through NLRP3 inflammasome after RD. The exact role of
IL-1β in neuronal diseases is still unclear. In the ischemic
injury model, inhibition of IL-1β is effective in preventing
neuronal damage.32 In contrast, inhibition of IL-1β does not
affect photoreceptor cell loss in the light injury model.34 Thus,
we examined whether cleaved IL-1β exacerbates photore-
ceptor cell death during RD. The caspase-1 inhibitor Ac-Tyr-
Val-Ala-Asp-chloromethylketone (YVAD) was administered to
the detached lesion to reduce production of cleaved IL-1β,
and the efficiency of inhibition was determined by western
blotting (Figures 5a and b). YVAD treatment dampened the
production of cleaved IL-1β by 61.9% compared with eyes
treated with vehicle. Next, we analyzed the effect of YVAD
treatment during RD using terminal deoxynucleotidyl trans-
ferase dUTP nick end labeling (TUNEL) as a marker of cell
death. The number of TUNEL-positive cells in the ONL was
reduced by 55.3% in WT mice treated with YVAD compared
with WT mice treated with vehicle at 24 h after RD (Figures 5c
Figure 2 Retinal detachment (RD) induces activation of IL-1β, which is diminished in Rip3-deficient mice. (a) The data show IL-1β levels detected by ELISA at 0 h (non-
treated eyes, n= 6) and from 6 to 120 h after induction of RD. n= 6–9. (b) Western blotting image shows representative data of cleaved IL-1β and β-actin in wild-type (WT) and
Rip3− /−mouse eyes after RD. (-): non-treated eyes. (c) Densitometry analyses of the western blotting data of (b) normalized to the intensity of β-actin (n= 4). Data are presented
as mean± s.d. *Po0.05, **Po0.01, ***Po0.001
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and d). The efficiency of YVAD treatment was similar to that
observed in Rip3− /−mice at 12 and 72 h after RD (Figure 6d).
Since YVAD inhibits caspase-4/11 in addition to caspase-1
(albeit to a lesser extent), we wanted to further investigate the
role of IL-1β in RD-induced photoreceptor cell death by using a
neutralizing anti-IL-1β antibody and Nlrp3− /−mice. As seen in
Figures 6a and b, neutralizing anti-IL-1β antibody adminis-
tered into the subretinal space (10 and 100 μg/ml) resulted in
significantly reduced numbers of TUNEL-positive cells com-
pared with control IgG (100 μg/ml). Although we used a high
dose of neutralizing antibody, it is still possible that we failed to
completely neutralize all IL-1β activity. For this reason, we
used Nlrp3− /− mice, which showed almost complete lack of
cleaved IL-1β compared with WT mice after RD (Figures 6c
and d). Similar to YVAD treatment and IL-1β-neutralizing
antibody, Nlrp3 deletion led to a significant but not complete
reduction in TUNEL-positive cells compared with WT mice at
24 h after RD (Figures 6e and f). These data suggest that
NLRP3 is important for inflammasome activation and produc-
tion of IL1-β after RD, and that inhibition of cleaved IL-1β
protects photoreceptors partially but not completely from RD
induced cell death. These data indicate that more mechan-
isms in addition to inflammasome are important for overall
photoreceptor cell loss after RD.
Discussion
In this study, we demonstrate that inflammasome activation
takes place in mouse and human eyes after RD, and is an
important mediator of photoreceptor cell loss. We further show
that Rip3 deletion attenuates inflammasome activation in a
mouse model of RD, and that the major sources of inflamma-
somes appear to be infiltrating macrophages rather than dying
photoreceptors (summarized in Figure 7).
In human eyes with RRD, liquefied vitreous fluid passes into
the potential subretinal space (newly formed space between
photoreceptors and RPE) through the retinal breaks. This
separation of the photoreceptors from the RPE by the
Figure 3 IL-1β is produced by the cells migrating into subretinal space. (a) ONL,
subretinal space, and RPE including choroid were circled as indicated in the left
column (red circles), followed by cutting with LCM. The right column shows the
images after cutting out the samples from the sections. Nuclei were stained with
Toluidine blue. INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal
pigment epithelium. Scale bars: 100 μm. (b) The graph shows the Il1b mRNA
expression in each layers with (+) RD (n= 12) or without (− ) RD (n= 6). ND, not
detectable. Data are presented as mean± s.d. *Po0.05
Figure 4 Macrophage recruitment is not altered in Rip3− /−mice. (a) The images
show macrophages stained with CD11b (green) that have migrated into the subretinal
space after 12 and 24 h in WT mice and Rip3− /− mice. Nuclei staining: TO-PRO-3
(blue). Scale bar: 50 μm. (b) The number of macrophages in the subretinal space at
12 and 24 h after RD (n= 6). (-): non-treated eyes. Data are presented as mean± s.d.
*Po0.05
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subretinal fluid results in photoreceptor cell death in part due to
lack of oxygenation and other trophic factors.3,43 Since
subretinal fluid does not occur in normal eyes, we could only
compare the levels of inflammatory cytokines in the subretinal
fluid of RRD patients with levels in the vitreous of control
patients. Our data showed significantly higher concentrations
of IL-1β in the subretinal fluid of RRD patients compared with
the vitreous fluid of control patients. Although IL-1β in the
vitreous fluid of RRD patients was higher than that of control
patients, IL-1β in the vitreous fluid of RRD patients was not as
high as the subretinal fluid of RRD patients, suggesting that
IL-1β is primarily concentrated in the subretinal space after
RD, rather than the vitreous fluid in RD patients. There is a lack
of published studies that have examined IL-1β in the phase of
photoreceptor cell death after RD. A study that examined late
scarring after RD (a late complication) found no relationship
Figure 5 Inhibition of caspase-1 reduces photoreceptor cell death after RD. (a) Inhibitor of caspase-1 (YVAD) was administered into the subretinal space, and cleaved IL-1β
was measured with western blotting to evaluate the efficiency of caspase-1 inhibition. (b) Densitometry analyses of the western blotting data of (a) normalized to the intensity of
β-actin (n= 4). (c) TUNEL staining (green) in WTand Rip3− /− mouse retinal sections. The eyes were treated with vehicle and YVAD and analyzed at 24 h after RD. Nuclei staining:
TO-PRO-3 (blue), scale bar: 50 μm. (d) Quantification of TUNEL-positive cells in the ONL after RD. n= 4–10 at each groups. (a and b) Data are presented as mean± s.d.
*Po0.05, **Po0.01
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between IL-1β and the development of proliferative vitreor-
etinopathy (scarring) after RD.38 Thus, upregulation of IL-1β in
the subretinal fluid appears to be an early rather than late
inflammatory cytokine signal after RD.
IL-1β is an important proinflammatory mediator produced at
sites of injury or infection to mediate the immune system’s
cytokine network and mount an appropriate cellular response.
Upregulation of IL-1β in the central nervous system (CNS)
after ischemic and traumatic brain injury has been reported in
animals.44,45 Increased IL-1β is also reported in ischemic
retinal injury and RDmodels in rats.32,41 In this study, we found
an increase in both pro- and cleaved IL-1β during the early
phase of RD in the mouse model. Total (pro- and cleaved)
IL-1β levels were observed to peak 12 h after RD, whereas the
mature cleaved form of IL-1β peaked later, at 24 h. The kinetics
of pro- and mature IL-1β follows the time course of
photoreceptor cell death after RD, peaking at 24 h. Synthesis
of pro-IL-1β is stimulated through TLRs, TNF receptor, or IL-1
receptor. Prior studies have shown TNFα to peak early (6 h)
after RD,41 suggesting that TNFα may be involved in priming
IL-1β. Following priming of IL-1β, production of cleavedmature
IL-1β occurs through activation of inflammasomes by DAMPs
released from dead cells. In contrast to previous reports by us
and others,4,46–48 our new modified model of RD49–51 exhibits
the peak of photoreceptor cell death around 24 h after RD,
likely due to a larger and more consistent volume of RD
compared with previous studies. Thus, it is reasonable that the
peak of mature IL-1β appears close to the peak of photo-
receptor cell death (at 24 h).
We found that Rip3− /− mice show attenuated inflamma-
some activation compared with WTmice during RD. There are
various explanations for this. One possibility is lower protein
synthesis of both pro-IL-1β and NLRP3 in Rip3− /− mice.
However, despite modest changes at the early time point of
mRNA expressions for IL-1β and Nlrp3 in Rip3− /− mice, the
protein levels of pro-IL-1β and NLRP3 were not altered.
Alternatively, different amount of DAMPs may be released
from dying photoreceptor cells during RD between WT mice
and Rip3− /− mice. Our group previously reported that Rip3-
deficient mice undergo relatively less photoreceptor cell death
than WT mice.5 We therefore expect that DAMPs, which
activate inflammasomes, will also be lower in Rip3− /− mice
Figure 6 Inhibition of IL-1β through Nlrp3 depletion or a neutralizing antibody diminishes photoreceptor cell death after RD. (a) Cleaved IL-1β was assessed at 24 h after RD
in WTand Nlrp3− /− mice eyes with western blotting. (b) Densitometry analyses of the western blotting data of (b) normalized to the intensity of β-actin (n= 4). (c and d) TUNEL
staining (green) in WTandNlrp3− /−mouse retinal sections at 24 h after RD (c) and quantification of TUNEL-positive cells in the ONL (d). WT: n= 8, Nlrp3− /−mice: n= 7. (e and
f) Neutralizing anti-IL-1β antibody (10 and 100 μg/ml) and control IgG were administered into subretina and analyzed at 24 h after RD. TUNEL staining (green) in mouse retinal
sections treated with antibody (e) and quantification of TUNEL-positive cells in the ONL (f). n= 8. Nuclei staining: TO-PRO-3 (blue), scale bar: 50 μm. Data are presented as
mean± s.d. *Po0.05, **Po0.01
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compared with WT mice. A third explanation is that RIP3
deletion in macrophages might affect inflammasome activa-
tion. Recent in vitro evidence suggests that there are RIP3-
dependent pathways that activate the NLRP3 inflammasome
under specific conditions, such as depletion of inhibitor of
apoptosis proteins (IAPs) or caspase-8 deficiency.52,53 How-
ever, more research is necessary to understand the interaction
between inflammasomes and the RIP3 pathway.
Most inflammasome studies have been focused on the
myeloid lineage, such as monocyte/macrophages, dendritic
cells, and neutorophils. However, there are several reports
that non-myeloid cells such as the RPE and keratinocytes also
activate inflammasomes.31,42,54 By means of LCM, we
demonstrated that the major origin of IL-1β in RD is not from
the dying photoreceptors cells but rather from the CD11b-
positive cells migrating into the subretinal space after RD.
Kawano et al.30 showed evidence that DAMPs increase after
RD; furthermore, they showed that histones, one class of
DAMPs, are preferentially located in the subretinal space,
which supports our findings of inflammasome activation in
subretinal macrophages after RD. Several studies have shown
that macrophages are recruited to the subretinal space
through Bruch’s membrane and the RPE during RD.55,56 Our
results showed a trend of increasing in Il1bmRNA expression
in the RPE/choroid complex after RD, though there was no
significant difference compared with the ONL and subretinal
space. Recent studies have shown that the RPE also activates
the NLRP3 inflammasome and induces IL-1β.31,42 It is unclear
how much of the Il1b mRNA in the RPE/choroid complex is
derived from the RPE itself compared with the choroid, since
the choroid contains circulating leukocytes in the chorioca-
pillaris, which may serve as a potential source of Il1b.
Moreover, there are macrophages migrating from the choroid
toward the subretinal space through the RPE during RD.55
Results from in vitro experiments performed by our group have
shown that the production of mature IL-1β from RPE cells is
several orders of magnitude less than macrophages
(Supplementary Figures S6a and b).
In the CNS, IL-1β shows both neurotoxicity and neuropro-
tection, depending on cell type, microenvironment, and
cytokine concentrations.57–59 As in the CNS, the role of
IL-1β in retinal diseases differs in various models. IL-1β
prevents photoreceptor cell death or at least induces no
toxicity in the light injured retinamodel.34,60 In contrast, IL-1β is
neurotoxic to photoreceptor cells in the retinal ischemicmodel,
as an IL-1 receptor antagonist confers neuroprotection against
glutamate toxicity.32 Under hypoxic or hypoglycemic stress,
IL-1β induces neuronal cell death in mixed cortical cell
cultures, while there is no effect during normoxia.61 During
RD, after separation from the RPE, photoreceptors are in a
relatively hypoxic and hypoglycemic state.6 In our model of
RD, caspase-1 inhibitor YVAD suppressed IL-1β production
and diminished cell death, although YVAD is also know to
inhibit (albeit to a lesser extend) caspase-4/11. For this reason
we used a neutralizing anti-IL-1β antibody, resulting in the
suppression of photoreceptor cell death after RD. Although we
used a high dose of neutralizing IL-1β antibody, it is still
possible that we might have failed to completely neutralize all
IL-1β. Thus, we employed Nlrp3− /− mice, which showed
almost complete lack of IL-1β after RD. These Nlrp3− /− mice,
similar to the mice treated with caspase-1 inhibitor or IL-1β
neutralizing antibody showed reduced but not complete
inhibition of cell loss after RD. Taken together, these data
suggest that IL-1β contributes partially but not completely to
photoreceptor cell death after RD. This is in contrast to
previous studies that have shown that administration of IL-1β
into the subretinal space does not increase photoreceptor cell
death during RD.41 This could be a result of endogenous IL-1β
signaling having already reached maximum levels, saturating
its effectors, and thus the addition of exogenous IL1-βmay no
longer lead to additional detrimental effect.
Figure 7 Model of mechanism in RD-induced photoreceptor cell death. After photoreceptor separation from RPE, caspase and RIPK mediated cell death ensues as well as
release of inflammatory mediators and DAMPs. Ensuing macrophage recruitment results in inflammasome activation and release of IL-1b. Rip3 deletion attenuates both directly
and indirectly inflammasome activation. Neutralization of IL-1b or inhibition of inflammasome activation partially diminishes cell death
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In contrast to caspase-1 inhibition in this study, previous
reports utilizing pan-caspase inhibitor did not show significant
protection for photoreceptor cell death after RD.5,46 This may
be related to the fact that inhibition of certain caspases lead to
activation of alternative cell death pathways. It has been
reported that when caspase-8 is inhibited, the RIP3-
dependent necrotic pathway is more activated than the
apoptotic pathway.8,9,62
The composition of subretinal fluid differs between human
RRD and animal models of RD. In humans, subretinal
fluid is primarily liquefied vitreous, serum transudate, and
contribution from aqueous humor,63,64 whereas in the animal
model a more viscous fluid (1% sodium hyaluronate) is
introduced. Sodium hyaluronate is the predominant glycosa-
minoglycan of human vitreous, and the concentration of
hyaluronan in adult human vitreous has reported to be
between 65 and 400 μg/ml (~0.0065–0.04%).65 In spite of
these differences, we found similarities in the inflammatory
responses such as activation of IL-1β and macrophage
infiltration between human RD and the animal model.66,67
In summary, our study shows for the first time that
photoreceptor injury by separation from RPE, as seen in
many human retinal diseases, induces inflammasomes in a
RIP3-dependent manner. It also shows for the first time that
IL-1β production is mainly derived from migrating macro-
phages and not from dying photoreceptors. We also demon-
strate that inhibition of IL-1β maturation by several
mechanisms (caspase-1 inhibition, neutralizing antibody,
and NLRP3 deletion) can partially protect photoreceptor cell
death after RD, suggesting a novel therapeutic target for
treatment of retinal and other neuronal diseases.
Materials and Methods
Patients and high sensitivity ELISA. The research protocol followed the
tenets of the Declaration of Helsinki and was approved by the Nagoya University
Hospital Ethics Review Board. All enrolled patients provided written informed
consent before the surgical procedure. All samples were collected at Nagoya
University Hospital during surgical treatments. Subretinal fluid samples were
collected during scleral buckling surgery from patients with primary RRD by making
a small incision of the sclera and choroid with diathermy coagulation as a routine
surgical procedure. The vitreous samples from primary RRD patients and control
vitreous samples from patients with either macular hole or vitreomacular traction
syndrome were collected by 25-gauge pars plana vitrectomy without dilution at the
start of vitrectomy. All the samples were immediately stored at − 80 °C. The
subretinal fluid and vitreous samples were spun down at 17 000 × g for 5 min,
followed by the measurement of IL-1β, TNFα, and IL-6 with High Sensitivity ELISA
(eBioscience, San Diego, CA, USA) according to the manufacturer’s protocol.
Animal models. All experimental procedures and research protocols were
approved by the Animal Care Committee of the Massachusetts Eye and Ear
Infirmary. C57BL/6 mice were purchased from Charles River Laboratories
International, Inc. (Wilmington, MA, USA). Rip3− /− mice were provided by DM Dixit
(Genentech).5 Nlrp3− /− mice and their control mice were purchased from The
Jackson Laboratory (Bar Harbor, ME, USA). RD was created in the eyes of 6- to 8-
week-old mice, according to the protocol described previously with slight
modifications.49 In brief, 4 μl of sodium hyaluronate (Provisc; Alcon, Fort Worth,
TX, USA) was injected into the subretinal space through the sclera and choroid of
mouse eyes. The scleral wound was sealed with octyl/butyl cyanoacrylate (GLUture;
Abbott Laboratories, Irving, TX, USA) to prevent leakage of sodium hyaluronate. For
inhibition of caspase-1, Ac-Tyr-Val-Ala-Asp-chloromethylketone (YVAD; Sigma-
Aldrich, St. Louis, MO, USA) was diluted with sodium hyaluronate to a final
concentration of 300 μM. For neutralization of IL-1β, anti-mouse IL-1β antibody and
control IgG (AF-401-NA and AB-108-C, R&D Systems, Minneapolis, MN, USA)
were diluted with sodium hyaluronate to a final concentration as indicated. The eyes
were collected at each time point as indicated, with western blotting, ELISA, and
TUNEL staining performed as per the protocols outlined below.
ELISA for mouse experiments. To prepare sample lysates, the mouse
eyes were lysed with M-PER lysis buffer (Thermo Scientific, Rockford, IL, USA)
containing Halt Phosphatase Inhibitor Cocktail (Thermo scientific) and cOmplete
Protease Inhibitor Cocktail (Roche, Indianapolis, IN, USA) after removing the
cornea, lens, and iris. Lysates were spun down at 17 000 × g for 5 min, and mouse
IL-1β, TNFα, IL-6, and VEGF in the lysates were measured with ELISA kits
(MLB00C, MTA00B, M6000B, and MMV00; R&D Systems), according to the
manufacturer’s protocol.
Western blotting. In all, 20 mM HEPES buffer (Sigma-Aldrich) containing Halt
Phosphatase Inhibitor Cocktail and cOmplete Protease Inhibitor Cocktail was used
as a lysis buffer. The eyes (with the cornea, lens, and iris removed) were
homogenized and ultracentifuged for 60 min at 50 000 × g to collect soluble proteins
as supernatants. The samples were then electrophoresed through NuPAGE 4-12%
Bis-Tris Gels (Life Technologies, Grand Island, NY, USA), and transferred onto
PVDF membranes. The following antibodies were used: rat anti-mouse IL-1β
(MAB4011; R&D Systems), rabbit anti-NLRP3 (5447; ProSci, Poway, CA, USA),
rabbit anti-cleaved caspase-3 (9661; Cell Signaling Technology, Danvers, MA, USA),
and rabbit anti-β-actin (4970; Cell Signaling Technology). The images of the blots
were taken with ChemiDoc MP and analyzed with Image Lab Software version 4.1
(Bio-Rad Laboratories, Hercules, CA, USA).
Laser capture microdissection. LCM was performed with the Leica
LMD7000 system and LMD application version 7.5 (Leica Microsystems, Buffalo
Grove, IL, USA). Enucleated mouse eyes were frozen in O.C.T Compound (Sakura
Finetek, Torrance, CA, USA) and cut into 20 μm sections on Frame slides (Leica
Microsystems). The sections were fixed with 75% ethanol for 30 s, washed with
nuclease-free water (Life Technologies) for 30 s, stained with 0.02% toluidine blue
solution (Sigma-Aldrich) for 20 s, and washed with nuclease-free water for 30 s. The
sections were then dehydrated with 75 and 95% ethanol for 30 s each, and twice
with 100% ethanol for 30 s. The tissues from the ONL, subretina (where the sensory
retina detached from the RPE), and the RPE (with choroid) were cut by laser and
collected into 0.5 ml tubes containing RNAlater (Life Technologies).
RNA extraction and RT-PCR. RNA extraction was performed with RNeasy
plus micro kit for the samples collected with LCM and RNeasy mini kit for the whole
mouse eye samples excluding the cornea, lens, and iris (Qiagen, Valencia, CA,
USA) according to manufacturer’s protocol. cDNA was synthesized with SuperScript
III Reverse Transcriptase and Oligo(dT) Primer (Life Technologies). Real-time PCR
was performed by StepOnePlus Real-Time PCR System (Life Technologies) and
analyzed with StepOne Software ver. 2.0 (Grand Island, NY, USA). Reactions were
performed with TaqMan Fast Universal PCR Master Mix and primers (18s rRNA:
Mm03928990_g1; Il1b: Mm00434228_m1; Nlrp3: Mm00840904_m1; Tnfa:
Mm99999068_m1; Il6: Mm00446190_m1, Life Technologies). The relative quantity
of mRNA expression was calculated by ΔΔCT method normalized to 18s rRNA as
endogenous control.
TUNEL staining and immunohistochemistry. Mouse eyes frozen in
O.C.T Compound were cut into 8 μm sections. TUNEL staining was performed with
ApopTag Fluorescein In Situ Apoptosis Detection Kit (S7110; EMD Millipore,
Billerica, MA, USA) according to the manufacturer’s protocol. For immunohis-
tochemistry, the frozen sections were postfixed with 4% paraformaldehyde for
15 min, blocked with 5% goat serum in phosphate-buffered saline (PBS). They were
then incubated with rat anti-CD11b antibody (BD Biosciences, San Jose, CA, USA)
at 4 °C overnight, followed by incubation with Alexa Fluor 488-conjugated goat anti-
rat IgG antibody (Life Technologies) and TO-PRO-3 Iodide (Life Technologies) for
30 min. All images obtained by AxioVision microscope (Zeiss, Chester, VA, USA)
were masked and randomized before analysis with ImageJ 1.44o (NIH, Bethesda,
MD, USA). TUNEL-positive cells in the center of the detached retina were counted
from at least four sections per eye and adjusted to the numbers of cells per 1 mm2
of the ONL. The CD11b-positive cells were counted in areas measuring 500
μm× 500 μm that included the ONL and subretinal space in the center of the
detached retina from two retinal sections per eye.
Statistical analyses. All statistical analyses were analyzed with GraphPad
Prism 5.0c (GraphPad software, La Jolla, CA, USA). For mouse experiments,
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one-way ANOVA followed by Dunnett’s multiple comparison test (Figure 2a,
compared with the data at 0 h), one-way ANOVA followed by Tukey’s test (Figures
3b, 5b, d, and 6b) and Student’s t-test (Figures 2c, 4b, 6d and f) were performed.
For human samples, Kruskal–Wallis test was used for Figure 1. Kruskal–Wallis test,
Fisher’s exact test, and Mann–Whitney U test were performed as indicated in
Table 1, since the human data were not normally distributed. The difference was
considered as significant at Po0.05.
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